INTRODUCTION:

Ruggero G. Fariello and Abraham Lieberman

Present and future approaches to Parkinson disease: From molecular insights to new therapeutic avenues
Neurology 2006 67: S1-4. [Full Text]  

ARTICLES:

C. Binda, F. Hubálek, M. Li, N. Castagnoli, D. E. Edmondson, and A. Mattevi

Structure of the human mitochondrial monoamine oxidase B: New chemical implications for neuroprotectant drug design
Neurology 2006 67: S5-7. [Abstract] [Full Text] [Figures Only]  

L. Zecca, F. A. Zucca, A. Albertini, E. Rizzio, and R. G. Fariello

A proposed dual role of neuromelanin in the pathogenesis of Parkinson’s disease
Neurology 2006 67: S8-11. [Abstract] [Full Text] [Figures Only]  

Tatyana D. Sotnikova, Marc G. Caron, and Raul R. Gainetdinov

DDD mice, a novel acute mouse model of Parkinson’s disease
Neurology 2006 67: S12-17. [Abstract] [Full Text] [Figures Only]  

C. Caccia, R. Maj, M. Calabresi, S. Maestroni, L. Faravelli, L. Curatolo, P. Salvati, and R. G. Fariello

Safinamide: From molecular targets to a new anti-Parkinson drug
Neurology 2006 67: S18-23. [Abstract] [Full Text] [Figures Only]  

F. Stocchi, L. Vacca, P. Grassini, M. F. De Pandis, G. Battaglia, C. Cattaneo, and R. G. Fariello

Symptom relief in Parkinson disease by safinamide: Biochemical and clinical evidence of efficacy beyond MAO-B inhibition
Neurology 2006 67: S24-29. [Abstract] [Full Text] [Figures Only]  

Ubaldo Bonuccelli and Paolo Del Dotto

New pharmacologic horizons in the treatment of Parkinson disease
Neurology 2006 67: S30-38. [Abstract] [Full Text]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.